BEAM vs BEN · rev $63.5M vs P/E 36, rev $8.77B
Beam Therapeutics Inc (BEAM) versus Franklin Resources Inc (BEN) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
BEAM currently screens at market cap $2.01B. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Not investment advice. Open the BEAM and BEN stock pages for the full models.
Not investment advice.